Camlin Fine Sciences Limited (NSE:CAMLINFINE) — Market Cap & Net Worth
Market Cap & Net Worth: Camlin Fine Sciences Limited (CAMLINFINE)
Camlin Fine Sciences Limited (NSE:CAMLINFINE) has a market capitalization of $263.70 Million (Rs24.38 Billion) as of May 3, 2026. Listed on the NSE stock exchange, this India-based company holds position #15480 globally and #767 in its home market, demonstrating a 18.62% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Camlin Fine Sciences Limited's stock price Rs126.94 by its total outstanding shares 192091613 (192.09 Million). Analyse Camlin Fine Sciences Limited (CAMLINFINE) cash flow conversion to see how efficiently the company converts income to cash.
Camlin Fine Sciences Limited Market Cap History: 2015 to 2026
Camlin Fine Sciences Limited's market capitalization history from 2015 to 2026. Data shows growth from $220.00 Million to $263.70 Million (0.90% CAGR).
Index Memberships
Camlin Fine Sciences Limited is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY MICROCAP 250
NIFTYMICROCAP250
|
$143.76 Billion | 0.18% | #160 of 250 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.20 Trillion | 0.01% | #541 of 750 |
Weight: Camlin Fine Sciences Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Camlin Fine Sciences Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Camlin Fine Sciences Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
Camlin Fine Sciences Limited's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $209.09 Million | $4.89 Billion | $358.24 Million | 0.04x | 0.58x |
| 2017 | $267.88 Million | $5.28 Billion | -$111.74 Million | 0.05x | N/A |
| 2018 | $113.32 Million | $7.15 Billion | -$296.43 Million | 0.02x | N/A |
| 2019 | $174.61 Million | $8.83 Billion | $5.77 Million | 0.02x | 30.25x |
| 2020 | $254.38 Million | $10.40 Billion | $303.19 Million | 0.02x | 0.84x |
| 2021 | $266.01 Million | $11.81 Billion | $509.63 Million | 0.02x | 0.52x |
| 2022 | $332.59 Million | $14.04 Billion | $606.78 Million | 0.02x | 0.55x |
| 2023 | $282.11 Million | $16.82 Billion | $521.06 Million | 0.02x | 0.54x |
| 2024 | $272.12 Million | $15.95 Billion | -$927.53 Million | 0.02x | N/A |
| 2025 | $308.29 Million | $16.67 Billion | -$1.39 Billion | 0.02x | N/A |
Competitor Companies of CAMLINFINE by Market Capitalization
Companies near Camlin Fine Sciences Limited in the global market cap rankings as of May 3, 2026.
Key companies related to Camlin Fine Sciences Limited by market ranking:
- Linde plc Ordinary Shares (NASDAQ:LIN): Ranked #91 globally with a market cap of $210.18 Billion USD.
- Air Liquide SA (PA:AI): Ranked #222 globally with a market cap of $108.00 Billion USD ( €92.38 Billion EUR).
- AIR LIQUIDE ADR 1/5/EO 11 (F:AILA): Ranked #232 globally with a market cap of $103.86 Billion USD ( €88.84 Billion EUR).
- Sherwin-Williams Co (NYSE:SHW): Ranked #334 globally with a market cap of $78.83 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #91 | Linde plc Ordinary Shares | NASDAQ:LIN | $210.18 Billion | $507.92 |
| #222 | Air Liquide SA | PA:AI | $108.00 Billion | €183.08 |
| #232 | AIR LIQUIDE ADR 1/5/EO 11 | F:AILA | $103.86 Billion | €36.60 |
| #334 | Sherwin-Williams Co | NYSE:SHW | $78.83 Billion | $318.00 |
Camlin Fine Sciences Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, Camlin Fine Sciences Limited's market cap moved from $220.00 Million to $ 263.70 Million, with a yearly change of 0.90%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs263.70 Million | -14.46% |
| 2025 | Rs308.29 Million | +13.29% |
| 2024 | Rs272.12 Million | -3.54% |
| 2023 | Rs282.11 Million | -15.18% |
| 2022 | Rs332.59 Million | +25.03% |
| 2021 | Rs266.01 Million | +4.57% |
| 2020 | Rs254.38 Million | +45.69% |
| 2019 | Rs174.61 Million | +54.08% |
| 2018 | Rs113.32 Million | -57.70% |
| 2017 | Rs267.88 Million | +28.12% |
| 2016 | Rs209.09 Million | -4.96% |
| 2015 | Rs220.00 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Camlin Fine Sciences Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $263.70 Million USD |
| MoneyControl | $263.70 Million USD |
| MarketWatch | $263.70 Million USD |
| marketcap.company | $263.70 Million USD |
| Reuters | $263.70 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Camlin Fine Sciences Limited
Camlin Fine Sciences Limited, together with its subsidiaries, research, develops, manufactures, and markets specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include basic ingredients, such as tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), and Ascorbyl Palmitate… Read more